|
Biomarker | Type of biomarker | Type of derived EVs | Diseases and pregnancy condition | Function | Reference |
|
Thyrotropin receptor | Receptor | Exosomes | Graves’ disease | Sequestering autoantibody and ameliorating autoantibody-mediated activation | [21] |
UL-16-binding protein | Protein | Exosomes | Placenta during pregnancy | Downregulate NK cell activity and inhibit maternal cytotoxicity | [25] |
MHC class I chain-related protein | Protein | Exosomes | Placenta during pregnancy | Downregulate NK cell activity and inhibit maternal cytotoxicity | [25] |
Syncytin-2 | Protein | Exosomes | Normal pregnancy | Exerting immunosuppressive effects on T cells | [37] |
Placental protein 13 | Protein | Exosomes or microvesicles | PE and other obstetric complications | Binding to glycosylated receptors, bringing about hemagglutination, immunoregulation and vasodilation | [48] |
Soluble fms-like tyrosine kinase-1 | Protein | Exosomes | PE | Attenuating the proliferation, migration, and tube formation of human umbilical vein endothelial cells | [51] |
Soluble endoglin | Protein | Exosomes | PE | Inhibiting the growth and tube formation of human umbilical vein endothelial cells | [51] |
MiR-201-3p | Nucleotide/noncoding RNA | Exosomes | PE | Having a role in the pathomechanism of PE | [57] |
MiR-155 | Nucleotide/noncoding RNA | Exosomes | PE | Inhibiting the expression of endothelial nitric oxide synthase | [58] |
MiR-136 and miR-495 | Nucleotide/noncoding RNA | MSC-derived exosomes | PE | Promising circulating biomarkers in early detection of PE | [59] |
MiR-210 | Nucleotide/noncoding RNA | Exosomes | PE | Produced by trophoblasts and participating in the intercellular communication | [60] |
Phosphoenolpyruvate carboxykinase | Kinase | Urine exosomes | Gestational diabetes mellitus | Affecting insulin resistance | [66] |
Sterile 20-like kinase 1 | Protein | Cardiac microvascular endothelial cell-derived exosomes | Diabetes | Inhibiting autophagy, promoting apoptosis and suppressing glucose metabolism | [70] |
EVs-encapsulated miRNAs | Nucleotide/noncoding RNA | EVs | Gestational diabetes mellitus | Serving as biomarkers for the diagnosis and treatment of gestational diabetes mellitus | [79–82] |
MiR-150 | Nucleotide/noncoding RNA | Piglet’s umbilical vein-derived EVs | FGR | Promoting angiogenesis | [86] |
MiR-21, miR-29a and miR-590-3p | Nucleotide/noncoding RNA | Urinary exosomes | ICP | Downregulating intercellular adhesion molecule 1 | [90] |
MiR-300 and miR-299-5p | Nucleotide/noncoding RNA | EVs | Congenital obstructive nephropathy | Reregulating renal fibrosis | [99] |
|